A comparative evaluation of treatments with 17β-estradiol and its brain-selective prodrug in a double-transgenic mouse model of Alzheimer's disease
Anna E. Tschiffely(University of Maryland, College Park), Mary Ann Ottinger(University of Houston), Rosemary A. Schuh(VA Maryland Health Care System), Katalin Prókai-Tátrai(University of North Texas), László Prókai(University of North Texas)
Cited by 34
Related Papers
Adverse Outcome Pathway (AOP) Development I: Strategies and Principles
|Toxicological Sciences|2014|725
Aging in Rhesus Monkeys: Relevance to Human Health Interventions
|Science|2004|363
GLP-1 Receptor Stimulation Reduces Amyloid-β Peptide Accumulation and Cytotoxicity in Cellular and Animal Models of Alzheimer's Disease
|Journal of Alzheimer s Disease|2010|325
Adverse Outcome Pathway Development II: Best Practices
|Toxicological Sciences|2014|261
Sex steroid levels in developing and adult male and female zebra finches (Poephila guttata)
|General and Comparative Endocrinology|1990|238